Sangamo Therapeutics’ CEO Sandy Macrae is bullish on his company’s ability to transform the genomic medicine arena.
Sangamo Therapeutics’ CEO Sandy Macrae is bullish on his company’s ability to transform the genomic medicine arena.
Copyright © 2024 | WordPress Theme by MH Themes